Posts by Kenneth Rosenfield, MD, MHCDS
Mass General Brigham Study Suggests Optimal Treatment for Limb Threatening Ischemia
Patients with chronic limb-threatening ischemia, a severe form of peripheral artery disease, are commonly treated with surgical bypass or endovascular therapy. A new Mass General Brigham study compared treatment results and indicated that bypass revascularization improves patient outcomes.
Mass General Provides Guidance for Anticoagulation in Patients with COVID-19
Physicians at Massachusetts General Hospital are continuously evaluating their recommendations for prophylactic anticoagulation for patients hospitalized for COVID-19.
FlowTriever System Is Safe, Effective for Treating Intermediate-Risk Pulmonary Embolism
In the first prospective trial of mechanical thrombectomy for acute intermediate-risk pulmonary embolism, the effectiveness and safety profiles of the FlowTriever Retrieval/Aspiration System were comparable to those of catheter-directed thrombolysis.
ACC 2019: A Media Roundup
At the 2019 ACC Annual Meeting, cardiologists from Massachusetts General Hospital presented and discussed research findings and advances in clinical care, such as predicting and preventing adverse cardiovascular events and optimizing patient care.
Despite Advanced Therapies, Mortality from Pulmonary Embolism Remains High
Advanced therapies for pulmonary embolism are independently associated with reduced risk of 90-day mortality, according to a review of a prospective database at Massachusetts General. However, overall mortality rates remain substantial.
ECMO Linked to Increased Survival Rate in High-Risk Pulmonary Embolism Patients
A Mass General team finds ECMO allows for more aggressive interventions to increase survival of high-risk pulmonary embolism patients.
Multidisciplinary pulmonary embolism response team
A new approach to treating pulmonary embolisms is a collaborative practice model involving pulmonary embolism response teams (PERTs).
Multidisciplinary Care for Pulmonary Embolism
Pulmonary embolism (PE) calls for a coordinated clinical approach. A new paradigm for care for PE was developed at Mass General.
Cardiac CT Mechanical Valve Prosthesis Dysfunction Diagnosis
A 27-year-old woman with history of type 1 truncus arteriosus presented with several months of progressive dyspnea for subspecialty ACHD care.
An Expert Statement on Critical Limb Ischemia
Questions persist over defining high-quality, cost-effective outcomes for critical limb ischemia.
Innovation in Carotid Artery Stenting (CAS)
For patients with cartoid artery stenosis at higher risk for surgical complications, carotid artery stenting is a lower-risk alternative to carotid endarterectomy.
What is PERT and How Can it Help Triage the PE Patient?
Kenneth Rosenfield, MD, of Mass General, discusses PERT, an institutionally-based multidisciplinary team that rapidly assesses and treats PE patients.
Kenneth Rosenfield, MD, MHCDS, is the Section Head for Vascular Medicine and Intervention, who specializes in complex cardiac and vascular interventions and directs the program for treatment of acute myocardial infarction (STEMI) in the cardiac catheterization laboratories. He has spearheaded the development of less-invasive therapies for patients with coronary and vascular disease, both at MGH and nationally, including treatment of Carotid, Kidney, and Leg artery narrowing using stents and other novel devices.